Core B: Biological Models, Biostatistics, Molecular Pathology and Microscopy
Core Director: Brett Bouma, PhD

The Biological Models, Biostatistics, Molecular Pathology and Microscopy Core, Core Component B, integrates novel biological models with newly developed biochemical and imaging assay platforms to enable the development of the treatments envisioned in the Program Projects.

This Core will also coordinate physically decentralized but centrally communicating biostatistics and pathological services to support experimental design and the interpretation of preclinical results.

The objective of Core B is to provide a service and research platform to increase the efficiency of microscopy, biostatistics and pathology techniques used by all four Program Projects.

In addition, another aim of Core B is to collaborate with Projects to develop new technologies. Thus, the Core will also have a research and development component to provide novel cancer models and tumor imaging technologies for the advancement of the Program Projects. For instance, once the drug containing TLNCs have been developed in Project 3, Core B will fabricate these to transfer this technology for use in Project 1.